Latimer, Nicholas R. http://orcid.org/0000-0001-5304-5585
Rutherford, Mark J. http://orcid.org/0000-0003-1557-6697
Funding for this research was provided by:
Cancer Research UK (C41379/A27583)
Yorkshire Cancer Research (S406NL)
Article History
Accepted: 4 June 2024
First Online: 5 July 2024
Declarations
: For the purpose of open access, the author has applied a Creative Commons Attribution (CC BY) licence to the Author Accepted Manuscript version arising from this submission.
: This work was supported by a Cancer Research UK grant for M.J.R. (grant C41379/A27583). M.J.R. was further supported by the National Institute for Health and Care Research (NIHR) Applied Research Collaboration East Midlands (ARC EM) and Leicester NIHR Biomedical Research Centre (BRC). N.R.L. is supported by Yorkshire Cancer Research (Award reference no. S406NL). The views expressed are those of the authors and not necessarily those of the NIHR, the Department of Health and Social Care or Yorkshire Cancer Research.
: N.R.L.'s institutions have received consultancy fees and funding, unrelated to the submitted work, from BMS, Merck, Sharpe and Dohme, and from Daiichi Sankyo, GSK, Janssen, Amgen, Sanofi, for projects N.R.L. has worked on.
: Both authors contributed to the study conception and design. Data collection and analysis were performed by N.R.L. with support from M.J.R. The first draft of the manuscript was written by N.R.L. and M.J.R. critically revised the work. Both authors read and approved the final manuscript.